Damon Bass

Efficacy and Safety of Subcutaneous Belimumab in Systemic Lupus Erythematosus: A Fifty‐Two–Week Randomized, Double‐Blind, Placebo‐Controlled Study

William Stohl, Andreas Schwarting, Masato Okada et al. · Arthritis & Rheumatology · 2017 · 417 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

A pivotal phase III, randomised, placebo-controlled study of belimumab in patients with systemic lupus erythematosus located in China, Japan and South Korea

Fengchun Zhang, Sang‐Cheol Bae, Damon Bass et al. · Annals of the Rheumatic Diseases · 2018 · 295 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

A secondary analysis of the Belimumab International Study in Lupus Nephritis trial examined effects of belimumab on kidney outcomes and preservation of kidney function in patients with lupus nephritis

Brad H. Rovin, Richard Furie, Y K Onno Teng et al. · Kidney International · 2021 · 198 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Safety and efficacy of intravenous belimumab in children with systemic lupus erythematosus: results from a randomised, placebo-controlled trial

Hermine I. Brunner, Carlos Abud‐Mendoza, Diego Oscar Viola et al. · Annals of the Rheumatic Diseases · 2020 · 193 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Healthcare utilization and cost of systemic lupus erythematosus in a US managed care health plan

Cindy Garris, Priti Jhingran, Damon Bass et al. · Journal of Medical Economics · 2013 · 120 citations · Full text

Pharmacy, Pharmacoeconomics, Managed Care +16